| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.95B | $3.72B | $3.47B |
| YoY Revenue Growth % | +6.3% | +7.1% | — |
| Gross Profit | $912.9M | $835.9M | — |
| Gross Margin % | 23.1% | 22.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $276.0M | $258.0M | $260.2M |
| Operating Margin % | 7.0% | 6.9% | 7.5% |
| Net Income (GAAP) | $135.1M | $138.4M | $142.9M |
| EBITDA (Normalized) | $342.3M | $318.6M | $385.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $329.4M | $326.8M | $408.7M |
| Capital Expenditures (CapEx) | $82.9M | $75.7M | $156.1M |
| Free Cash Flow (FCF) | $246.5M | $251.2M | $252.6M |
| FCF Margin % | 6.2% | 6.8% | 7.3% |
| Return on Invested Capital (ROIC %) | 8.9% | 8.5% | 8.2% |
| Cash & Short-Term Equivalents | $26.4M | $33.6M | — |
| Total Debt (Short + Long Term) | $1.28B | $1.31B | $973.8M |
| Total Stockholders' Equity | $1.18B | $1.13B | $2.00B |